Liang Jiachang, Lian Lirong, Liang Shaotian, Zhao Haibo, Shu Gao, Chao Jiwei, Yuan Chao, Zhai Mingyu
Department of Graduate Schools, Guangzhou University of Chinese Medicine, Guangzhou, China.
Department of Spine Surgery, Shenzhen Luohu District Chinese Medicine Hospital, Shenzhen, China.
World Neurosurg. 2022 Mar;159:e91-e102. doi: 10.1016/j.wneu.2021.12.005. Epub 2021 Dec 7.
As an emerging minimally invasive endoscopic technique, unilateral biportal endoscopic spinal surgery (UBESS) has the advantages of flexibility, a wide and clear field of view, and less soft tissue damage. However, the clinical evidence is insufficient and controversy exists regarding UBESS for the treatment of lumbar spinal stenosis (LSS). In the present meta-analysis, we investigated the clinical efficacy and complications of UBESS for the treatment of LSS.
The PubMed, Embase, Web of Science, and Cochrane Library databases were searched through to June 1, 2021 to identify all reported studies on UBESS for LSS. Only English-language studies with original reported data from ≥30 cases were considered for inclusion. The patient demographics, operative time, hospital stay, complications, visual analog scale (VAS) score, Oswestry disability index, and Macnab criteria were extracted. Quality assessment was performed using the Cochrane collaboration tool for randomized controlled trials and the Newcastle-Ottawa scale for retrospective studies. A meta-analysis was performed using a random or fixed effect model according to the heterogeneity.
Thirteen studies with 586 patients and 607 operation levels were included. The mean single-level operative time, hospital stay, and follow-up duration were 61.10 minutes, 2.32 days, and 14.7 months, respectively. At the final follow-up visit, the mean VAS score for leg pain had decreased from 7.23 preoperatively to 1.83 postoperatively, the mean VAS score for back pain had decreased from 6.30 to 1.95, and the mean Oswestry disability index had significantly improved from 56.99 to 17.83. The average satisfied outcome (excellent or good using the Macnab criteria) was 86%. The overall complication rate was 5%, and the most common complication was a dural tear, with an incidence of 2%, followed by epidural hematoma with an incidence of 1%. The remaining complications were nerve root injury, inadequate decompression, and postoperative headache.
From the available clinical results and experience from reported studies, UBESS for LSS is a feasible and effective approach and a worthwhile choice for clinicians. However, the complications associated with the procedure should also be seriously considered.
作为一种新兴的微创内镜技术,单侧双孔道内镜下脊柱手术(UBESS)具有操作灵活、视野宽广清晰、软组织损伤小等优点。然而,关于UBESS治疗腰椎管狭窄症(LSS)的临床证据不足,且存在争议。在本荟萃分析中,我们研究了UBESS治疗LSS的临床疗效和并发症。
检索截至2021年6月1日的PubMed、Embase、Web of Science和Cochrane图书馆数据库,以确定所有关于UBESS治疗LSS的报道研究。仅纳入≥30例原始报道数据的英文研究。提取患者人口统计学资料、手术时间、住院时间、并发症、视觉模拟量表(VAS)评分、Oswestry功能障碍指数和Macnab标准。使用Cochrane协作工具对随机对照试验进行质量评估,使用纽卡斯尔-渥太华量表对回顾性研究进行质量评估。根据异质性采用随机或固定效应模型进行荟萃分析。
纳入13项研究,共586例患者、607个手术节段。平均单节段手术时间、住院时间和随访时间分别为61.10分钟、2.32天和14.7个月。在末次随访时,腿痛的平均VAS评分从术前的7.23降至术后的1.83,背痛的平均VAS评分从6.30降至1.95,平均Oswestry功能障碍指数从56.99显著改善至17.83。平均满意结果(根据Macnab标准为优或良)为86%。总体并发症发生率为5%,最常见的并发症是硬脊膜撕裂,发生率为2%,其次是硬膜外血肿,发生率为1%。其余并发症为神经根损伤、减压不充分和术后头痛。
从已有的临床结果和报道研究的经验来看,UBESS治疗LSS是一种可行且有效的方法,对临床医生来说是一个值得考虑的选择。然而,与该手术相关的并发症也应予以认真考虑。